These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 12492182

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
    Attwood SE, Lewis CJ, Caplin S, Hemming K, Armstrong G.
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
    [Abstract] [Full Text] [Related]

  • 23. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.
    Sujendran V, Sica G, Warren B, Maynard N.
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):763-6. PubMed ID: 16188449
    [Abstract] [Full Text] [Related]

  • 24. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
    Etienne J, Dorme N, Bourg-Heckly G, Raimbert P, Fékété F.
    Bull Acad Natl Med; 2000 Nov; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
    [Abstract] [Full Text] [Related]

  • 25. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
    Beaumont H, Gondrie JJ, McMahon BP, Pouw RE, Gregersen H, Bergman JJ, Boeckxstaens GE.
    Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
    Ortner M-, Zumbusch K, Liebetruth J, Ebert B, Fleige B, Dietel M, Lochs H.
    Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
    [Abstract] [Full Text] [Related]

  • 28. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P, Shaheen NJ, Katzka D, Bergman JJGHM.
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [Abstract] [Full Text] [Related]

  • 29. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.
    Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR.
    Am J Gastroenterol; 2000 Dec; 95(12):3383-7. PubMed ID: 11151865
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia.
    Connor MJ, Sharma P.
    Thorac Surg Clin; 2004 Feb; 14(1):87-94. PubMed ID: 15382312
    [Abstract] [Full Text] [Related]

  • 33. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL.
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [Abstract] [Full Text] [Related]

  • 34. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
    Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE.
    Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
    [Abstract] [Full Text] [Related]

  • 35. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
    Pech O, Ell C.
    Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
    [Abstract] [Full Text] [Related]

  • 36. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
    Conio M, Blanchi S, Lapertosa G, Ferraris R, Sablich R, Marchi S, D'Onofrio V, Lacchin T, Iaquinto G, Missale G, Ravelli P, Cestari R, Benedetti G, Macrì G, Fiocca R, Munizzi F, Filiberti R.
    Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768
    [Abstract] [Full Text] [Related]

  • 37. Molecular evaluation of ablative therapy of Barrett's oesophagus.
    Hage M, Siersema PD, Vissers KJ, Steyerberg EW, Haringsma J, Kuipers EJ, van Dekken H.
    J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
    [Abstract] [Full Text] [Related]

  • 38. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.
    Moss A, Bourke MJ, Hourigan LF, Gupta S, Williams SJ, Tran K, Swan MP, Hopper AD, Kwan V, Bailey AA.
    Am J Gastroenterol; 2010 Jun; 105(6):1276-83. PubMed ID: 20179694
    [Abstract] [Full Text] [Related]

  • 39. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V, Schlup M, Lübcke R, Livingstone V, Schultz M.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [Abstract] [Full Text] [Related]

  • 40. High-grade dysplasia in Barrett's oesophagus.
    Wright TA.
    Br J Surg; 1997 Jun; 84(6):760-6. PubMed ID: 9189080
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.